SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-299774
Filing Date
2014-08-07
Accepted
2014-08-07 09:36:13
Documents
13
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d728701d10q.htm 10-Q 523783
2 EX-10.1 d728701dex101.htm EX-10.1 19085
3 EX-10.2 d728701dex102.htm EX-10.2 23564
4 EX-31.1 d728701dex311.htm EX-31.1 5707
5 EX-31.2 d728701dex312.htm EX-31.2 5706
6 EX-32.1 d728701dex321.htm EX-32.1 3086
7 EX-32.2 d728701dex322.htm EX-32.2 3116
  Complete submission text file 0001193125-14-299774.txt   3007861

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT fprx-20140630.xml EX-101.INS 406568
9 XBRL TAXONOMY EXTENSION SCHEMA fprx-20140630.xsd EX-101.SCH 30290
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fprx-20140630_cal.xml EX-101.CAL 42914
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fprx-20140630_def.xml EX-101.DEF 70498
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE fprx-20140630_lab.xml EX-101.LAB 238442
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fprx-20140630_pre.xml EX-101.PRE 154192
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36070 | Film No.: 141022110
SIC: 2834 Pharmaceutical Preparations